ChengDa Pharmaceuticals Co., Ltd. (SHE:301201)

China · Delayed Price · Currency is CNY

33.71

-0.96 (-2.77%)

At close: Jun 10, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Specialty Chemicals	406.37M	333.13M	414.30M	411.46M	415.73M
Specialty Chemicals Growth	21.99%	-19.59%	0.69%	-1.03%	11.44%
Total	406.37M	333.13M	414.30M	411.46M	415.73M
Total Growth	21.99%	-19.59%	0.69%	-1.03%	11.44%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	260.24M	223.50M	264.94M	205.85M	194.96M
China Growth	16.44%	-15.64%	28.70%	5.59%	-20.40%
Foreign	146.13M	109.63M	149.37M	205.61M	220.76M
Foreign Growth	33.29%	-26.60%	-27.35%	-6.86%	72.42%
Total	406.37M	333.13M	414.30M	411.46M	415.73M
Total Growth	21.99%	-19.59%	0.69%	-1.03%	11.47%

Source: S&P Global Market Intelligence.